PE deal volume and value rose slightly in Q3; Archimed buys Ark Diagnostics in $428m carveout
Dealmaking picked up in the third quarter, and PEI Group's data journalism team crunched the numbers from S&P Global Market Intelligence data to show where the most activity is taking place; Archimed carves out Ark Diagnostics from Soulbrain; a new episode of PEI Group’s Disruption Matters podcast miniseries, in which PE executives discuss charting a better path to growth in 2026.
28 October 2025•4 mins read
